© 2004 BMJ Publishing Group Ltd & Association of Clinical Pathologists
ORIGINAL ARTICLE
The investigation of short stature: a survey of practice in Wales and suggested practical guidelines
1 Department of Medical Biochemistry, University Hospital of Wales, Cardiff, UK
2 Department of Child Health, University of Wales College of Medicine, Cardiff, UK
Correspondence to:
Correspondence to:
Dr C Evans
Department of Medical Biochemistry, University of Wales College of Medicine, Heath Park, Cardiff, CF14 4XW, UK; carol.evans{at}cardiffandvale.wales.nhs.uk
Aim: To survey the investigation of short stature in Wales and suggest guidelines to improve practice.
Methods: Questionnaires were circulated to paediatricians and consultant clinical biochemists or consultant chemical pathologists at 13 Welsh hospitals where children with short stature are investigated.
Results: A 100% response was obtained from laboratory and clinical staff. Clinicians screened 150 patients each year (median, 10). Growth hormone (GH) deficiency was subsequently diagnosed in 030% (median, 10%) and GH treatment started in 30100% (median, 100%) of patients. Five paediatricians and eight laboratories had written investigative protocols. Investigation of GH secretion was initiated in some centres before a complete clinical evaluation was carried out. Various screening tests for GH deficiency, including insulin-like growth factor 1 (IGF-1), random GH, and exercise tests were used. The clonidine stimulation test was used to assess the GH axis in most centres but eight different protocols were described. GH was measured in four Welsh laboratories using two automated immunoassay methods. However, nine different ranges of cutoff values for defining abnormal GH responses were quoted, and in three centres laboratories and paediatricians quoted different cutoffs.
Conclusion: This survey demonstrates the need for practical guidelines for the investigation and management of short stature in children, agreed by paediatricians and their laboratory colleagues. The guidelines should encompass the initial clinical investigation, assessment of the GHIGF-1 axis (using standardised protocols), and provision for the transition to adult management. This article presents practical guidelines based on published points for good practice.
Keywords: growth hormone deficiency; short stature
Abbreviations: GH, growth hormone; GDH, growth hormone deficiency; IGF-1, insulin-like growth factor 1; IGFBP3, insulin-like growth factor binding protein 3
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Drake, A. J, Kelnar, C. J H
(2006). The evaluation of growth and the identification of growth hormone deficiency. EDUCATION AND PRACTICE
91: ep61-ep67
[Full Text] -
(2004). Lucina. Arch. Dis. Child.
89: 798-798
[Full Text] -
Ayling, R
(2004). More guidance on growth hormone deficiency. J. Clin. Pathol.
57: 123-125
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
